Clinical trial
Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients…
NCT00002553 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002553 |
|---|---|
| Title | Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer |
| Official title | TREATMENT OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES USING MARROW TRANSPLANTATION FROM UNRELATED DONORS MATCHED FOR HLA OR INCOMPATIBLE FOR ONE HLA LOCUS ANTIGEN |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cyclophosphamide, allogeneic bone marrow transplantation, low-LET cobalt-60 gamma ray therapy |
| Enrollment | 50 |
| Start date | Aug 1, 1990 |
| Completion | Jun 1, 2003 |
| First posted | Apr 26, 2004 |
| Last update posted | Nov 30, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: